神奇制药
(600613)
| 流通市值：28.18亿 | | | 总市值：31.40亿 |
| 流通股本：4.79亿 | | | 总股本：5.34亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 482,370,291.85 | 594,091,354.93 | 611,086,590.92 | 681,531,797.1 |
| 交易性金融资产 | 232,701,962.23 | 110,397,718.6 | 210,653,315.07 | 40,000,000 |
| 应收票据及应收账款 | 557,155,068.97 | 584,095,896.4 | 466,356,498.65 | 454,426,994.21 |
| 其中：应收票据 | 234,990,499.62 | 263,288,491.57 | 148,761,035.11 | 144,943,972.89 |
| 应收账款 | 322,164,569.35 | 320,807,404.83 | 317,595,463.54 | 309,483,021.32 |
| 应收款项融资 | 57,662,075.63 | 58,606,893.63 | 44,193,818.36 | 72,929,868.78 |
| 预付款项 | 15,735,188.03 | 14,524,878.55 | 24,313,693.12 | 29,144,306.56 |
| 其他应收款合计 | 10,599,894.73 | 8,596,465.24 | 10,071,487.26 | 7,762,004.51 |
| 存货 | 217,625,407.81 | 197,499,277.85 | 218,946,576.4 | 208,901,109.15 |
| 其他流动资产 | 5,353,652.07 | 86,107,261.32 | 4,487,998.86 | 4,089,290.31 |
| 流动资产合计 | 1,579,203,541.32 | 1,653,919,746.52 | 1,590,109,978.64 | 1,498,785,370.62 |
| 非流动资产: | | | | |
| 长期股权投资 | 4,186,511.61 | 4,186,511.62 | 3,893,769.98 | 3,893,769.98 |
| 其他权益工具投资 | 73,762,594.32 | 82,003,828.55 | 82,824,572.81 | 78,565,278.05 |
| 投资性房地产 | 5,145,968.61 | 5,236,481.1 | 5,326,993.59 | 5,417,506.08 |
| 固定资产 | 947,747,652.89 | 965,173,005.11 | 842,762,395.41 | 856,105,837.42 |
| 在建工程 | 43,788,235.93 | 41,296,400.24 | 176,448,086.97 | 173,086,716.26 |
| 使用权资产 | 22,473,192.94 | 24,386,916.71 | 15,205,313.31 | 18,032,250.52 |
| 无形资产 | 92,719,444.65 | 93,295,881.88 | 94,750,968.64 | 95,606,435.79 |
| 商誉 | 243,848,737.16 | 243,848,737.16 | 243,848,737.16 | 243,848,737.16 |
| 长期待摊费用 | 2,290,179.8 | 2,332,958.26 | 1,108,115.01 | 1,312,536.32 |
| 递延所得税资产 | 25,773,655.39 | 25,218,868.2 | 24,836,258.68 | 24,420,736.77 |
| 其他非流动资产 | 3,419,750.36 | 4,225,827.25 | 5,067,226.58 | 4,937,573.28 |
| 非流动资产合计 | 1,465,155,923.66 | 1,491,205,416.08 | 1,496,072,438.14 | 1,505,227,377.63 |
| 资产总计 | 3,044,359,464.98 | 3,145,125,162.6 | 3,086,182,416.78 | 3,004,012,748.25 |
| 流动负债: | | | | |
| 短期借款 | 61,727,594.45 | 61,914,686.12 | 32,000,000 | 32,000,000 |
| 应付票据及应付账款 | 234,803,307.38 | 241,895,583.36 | 242,426,879.3 | 215,189,636.73 |
| 应付账款 | 234,803,307.38 | 241,895,583.36 | 242,426,879.3 | 215,189,636.73 |
| 合同负债 | 47,648,130.77 | 35,583,416.85 | 64,067,664.18 | 46,175,590.05 |
| 应付职工薪酬 | 15,247,729.39 | 19,682,925.87 | 13,155,178.75 | 12,010,954.71 |
| 应交税费 | 18,546,589.91 | 19,080,448.5 | 27,415,650.19 | 19,357,753.39 |
| 其他应付款合计 | 63,592,734.87 | 52,558,533.58 | 48,761,401.95 | 61,364,793.8 |
| 应付股利 | 195,409.36 | 195,409.36 | 195,409.36 | 195,409.37 |
| 一年内到期的非流动负债 | 16,950,804.63 | 46,668,259.64 | 42,507,108.42 | 43,276,644.62 |
| 其他流动负债 | 147,068,945.88 | 143,437,093.07 | 63,443,992.28 | 46,241,432.25 |
| 流动负债合计 | 605,585,837.28 | 620,820,946.99 | 533,777,875.07 | 475,616,805.55 |
| 非流动负债: | | | | |
| 长期借款 | - | 88,560,000 | 116,740,000 | 116,740,000 |
| 租赁负债 | 11,509,161.52 | 12,348,892.42 | 2,803,635.2 | 3,841,247.82 |
| 递延收益 | 8,610,699.42 | 8,838,559.53 | 5,447,500 | 1,515,000 |
| 递延所得税负债 | 15,270,525.23 | 17,023,829.84 | 18,008,980.39 | 16,766,263.22 |
| 非流动负债合计 | 35,390,386.17 | 126,771,281.79 | 143,000,115.59 | 138,862,511.04 |
| 负债合计 | 640,976,223.45 | 747,592,228.78 | 676,777,990.66 | 614,479,316.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 534,071,628 | 534,071,628 | 534,071,628 | 534,071,628 |
| 资本公积 | 968,991,239.37 | 968,991,239.37 | 968,991,239.37 | 968,991,229.37 |
| 其他综合收益 | 23,725,066.06 | 29,901,799.09 | 30,517,357.29 | 27,322,886.22 |
| 盈余公积 | 81,560,308.17 | 81,560,308.17 | 77,060,188.77 | 77,060,188.77 |
| 未分配利润 | 718,692,288.61 | 705,808,082.91 | 722,365,736.11 | 704,872,278.62 |
| 归属于母公司股东权益合计 | 2,327,040,530.21 | 2,320,333,057.54 | 2,333,006,149.54 | 2,312,318,210.98 |
| 少数股东权益 | 76,342,711.32 | 77,199,876.28 | 76,398,276.58 | 77,215,220.68 |
| 股东权益合计 | 2,403,383,241.53 | 2,397,532,933.82 | 2,409,404,426.12 | 2,389,533,431.66 |
| 负债和股东权益合计 | 3,044,359,464.98 | 3,145,125,162.6 | 3,086,182,416.78 | 3,004,012,748.25 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |